How big is the Asia-Pacific Diabetes Care Devices Market?

The Asia-Pacific Diabetes Care Devices Market size is expected to reach USD 22.77 billion in 2024 and grow at a CAGR of 3.5% to reach USD 26.91 billion by 2029. Read More

What is the current Asia-Pacific Diabetes Care Devices Market size?

In 2024, the Asia-Pacific Diabetes Care Devices Market size is expected to reach USD 22.77 billion. Read More

Who are the key players in Asia-Pacific Diabetes Care Devices Market?

F. Hoffmann-La Roche AG, Medtronic PLC, Abbott Diabetes Care, Novo Nordisk A/S and Eli Lilly and Company are the major companies operating in the Asia-Pacific Diabetes Care Devices Market. Read More

What years does this Asia-Pacific Diabetes Care Devices Market cover, and what was the market size in 2023?

In 2023, the Asia-Pacific Diabetes Care Devices Market size was estimated at USD 22 billion. The report covers the Asia-Pacific Diabetes Care Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Diabetes Care Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Asia-Pacific Diabetes Care Devices Market Share

Statistics for the 2023 & 2024 Asia-Pacific Diabetes Care Devices market share, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Diabetes Care Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Asia-Pacific Diabetes Care Devices Industry

The Asia-Pacific Diabetes Care Devices Market is fragmented, with major companies like Abbott, LifeScan, F. Hoffmann-La Roche AG, and Novo Nordisk, and other generic players. They are strategically working to develop new technologies in diabetes care devices, which is likely to drive the market in the future.